Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LDL-receptor mutations in Europe.

George V Z Dedoussis1, Hartmut Schmidt, Janine Genschel

  • 1Department of Science Dietetics-Nutrition, Harokopio University of Athens, Athens, Greece.

Human Mutation
|November 4, 2004
PubMed
Summary

Familial hypercholesterolemia (FH) is a genetic disorder causing high cholesterol. Identifying mutations in genes like LDLR is key to understanding and treating this condition effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of multivariable prognostic machine learning models to identify patients at risk for inadequate bowel preparation when undergoing colonoscopy: a prospective, multicentre study.

BMJ open gastroenterology·2026
Same author

Prognostic Relevance of Ascites Volume and Dynamics in Outpatients with Cirrhosis: A Prospective Cohort Study.

Journal of clinical medicine·2026
Same author

Early Conversion to Once-Daily MeltDose<sup>®</sup> Extended-Release Tacrolimus (LCPT) in Liver Transplant Patients.

Journal of clinical medicine·2025
Same author

Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model.

JHEP reports : innovation in hepatology·2025
Same author

Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX study.

Critical care (London, England)·2025
Same author

The intracellular Ca<sup>2+</sup> sensitivity of transmitter release in glutamatergic neocortical boutons.

Science (New York, N.Y.)·2025

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiovascular Disease

Background:

  • Familial hypercholesterolemia (FH) is characterized by significantly elevated serum cholesterol, xanthomas, and a genetic predisposition to premature coronary artery disease (CAD).
  • The low-density lipoprotein (LDL) receptor (LDLR) plays a critical role in cholesterol transport to cells; its dysfunction is a primary cause of FH.
  • Genetic variations in LDLR, apolipoprotein B-100 (APOB), PCSK9, and ARH gene impact LDL metabolism and FH phenotypes.

Purpose of the Study:

  • To review European data on LDLR mutations in Familial hypercholesterolemia.
  • To explore the heterogeneity and phenotypic penetrance associated with LDLR mutations.
  • To emphasize the importance of genetic diagnosis in managing FH.

Main Methods:

  • Review of published European LDLR mutation data.
  • Analysis of genetic characterization in FH patients.
  • Correlation of genetic findings with clinical phenotypes.

Main Results:

  • LDLR mutations are a common cause of autosomal dominant FH, with heterozygosity affecting approximately 1 in 500 individuals.
  • Genetic variations in LDLR, APOB, PCSK9, and ARH contribute to varying degrees of hypercholesterolemia and cholesterol deposition.
  • Phenotypic expression of FH is influenced by genetic heterogeneity and additional factors beyond LDLR mutations.

Conclusions:

  • Understanding LDL metabolism and genetic factors is crucial for managing serum LDL-cholesterol concentrations.
  • Genetic diagnosis is a valuable tool for effective treatment of FH, a potentially fatal disease.
  • Further research into LDLR mutation data highlights the complexity of FH and its clinical outcomes.

Related Experiment Videos